These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3596072)

  • 1. Effects of rationalizing drug treatment of patients with epilepsy and mental retardation.
    Beghi E; Bollini P; Di Mascio R; Cerisola N; Merloni T; Manghi E
    Dev Med Child Neurol; 1987 Jun; 29(3):363-9. PubMed ID: 3596072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate in patients with epilepsy and intellectual disability.
    Martin P; Schreiner A; Rettig K; Schäuble B
    Epilepsy Behav; 2009 Mar; 14(3):496-502. PubMed ID: 19162230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation.
    Sunder TR; McKee JR; Hammer AE; Vuongc A
    Curr Med Res Opin; 2006 Apr; 22(4):693-702. PubMed ID: 16684430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability.
    Leunissen CL; de la Parra NM; Tan IY; Rentmeester TW; Vader CI; Veendrick-Meekes MJ; Aldenkamp AP
    Res Dev Disabil; 2011; 32(6):2660-8. PubMed ID: 21752594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive lamotrigine for refractory epilepsy in adolescents with mental retardation.
    McKee JR; Sunder TR; Vuong A; Hammer AE
    J Child Neurol; 2006 May; 21(5):372-9. PubMed ID: 16901441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of psychotropic and anti-epileptic drug use in mentally handicapped students].
    Meins W
    Z Kinder Jugendpsychiatr; 1991 Mar; 19(1):15-8. PubMed ID: 1927052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic drugs and mental retardation: 2. A comparison of psychoactive drug use before and after discharge from hospital to community.
    Thinn K; Clarke DJ; Corbett JA
    J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():397-407. PubMed ID: 1979993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenging behavior in adults with epilepsy and intellectual disability: An analysis of epilepsy characteristics.
    van Ool JS; Snoeijen-Schouwenaars FM; Tan IY; Jurgen Schelhaas H; Aldenkamp AP; Hendriksen JGM
    Epilepsy Behav; 2018 Sep; 86():72-78. PubMed ID: 30153936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience with levetiracetam in childhood epilepsy].
    Neuwirth M; Saracz J; Hegyi M; Paraicz E; Kollár K; Móser J; Rosdy B; Herczegfalvi A; Fogarasi A
    Ideggyogy Sz; 2006 May; 59(5-6):179-82. PubMed ID: 16786712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic medication use in patients with epilepsy: effect on seizure frequency.
    Gross A; Devinsky O; Westbrook LE; Wharton AH; Alper K
    J Neuropsychiatry Clin Neurosci; 2000; 12(4):458-64. PubMed ID: 11083162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiepileptic drugs, occurrence of seizures and effect of co-administration of potential seizure threshold-lowering psychotropic drugs in adults with intellectual disability who have epilepsy.
    Monaghan R; O'Dwyer M; Luus R; Mulryan N; McCallion P; McCarron M; Henman MC
    J Appl Res Intellect Disabil; 2021 May; 34(3):818-829. PubMed ID: 33530136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings.
    Clarke DJ; Kelley S; Thinn K; Corbett JA
    J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():385-95. PubMed ID: 2266549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decade of modern epilepsy therapy in institutionalized mentally retarded patients.
    Pellock JM; Hunt PA
    Epilepsy Res; 1996 Nov; 25(3):263-8. PubMed ID: 8956925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term course of epilepsy in a large cohort of intellectually disabled patients.
    Huber B; Hauser I; Horstmann V; Jokeit G; Liem S; May T; Meinert T; Robertson E; Schorlemmer H; Wagner W; Seidel M
    Seizure; 2007 Jan; 16(1):35-42. PubMed ID: 17157535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological outcomes in people with mental retardation and epilepsy.
    Kelly K; Stephen LJ; Brodie MJ
    Epilepsy Behav; 2004 Feb; 5(1):67-71. PubMed ID: 14751209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigabatrin in epilepsy in mentally retarded patients.
    Matilainen R; Pitkänen A; Ruutiainen T; Mervaala E; Riekkinen P
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):113S-118S. PubMed ID: 2757902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopharmacoepidemiology of mental retardation: 1966 to 1995.
    Singh NN; Ellis CR; Wechsler H
    J Child Adolesc Psychopharmacol; 1997; 7(4):255-66. PubMed ID: 9542696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discontinuing medication in epileptic children: a study of risk factors related to recurrence.
    Gherpelli JL; Kok F; dal Forno S; Elkis LC; Lefevre BH; Diament AJ
    Epilepsia; 1992; 33(4):681-6. PubMed ID: 1628584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.
    Gidal BE; Walker JK; Lott RS; Shaw R; Speth J; Marty KJ; Rutecki P
    Seizure; 2000 Mar; 9(2):131-6. PubMed ID: 10845738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mono- or polypharmacotherapy in institutionalized epileptic children with severe mental retardation? A team approach for optimizing antiepileptic therapy.
    Ferngren H; Akerström I; Rane A
    Acta Paediatr Scand; 1991 Apr; 80(4):458-65. PubMed ID: 2058396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.